Cargando…

The Interaction of Human Papillomavirus Infection and Prostaglandin E(2) Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics

Chronic infection by high-risk human papillomaviruses (HPV) and chronic inflammation are factors associated with the onset and progression of several neoplasias, including cervical cancer. Oncogenic proteins E5, E6, and E7 from HPV are the main drivers of cervical carcinogenesis. In the present arti...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Quiroz, Janice, Vázquez-Almazán, Bismarck, García-Becerra, Rocío, Díaz, Lorenza, Avila, Euclides
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406919/ https://www.ncbi.nlm.nih.gov/pubmed/36010605 http://dx.doi.org/10.3390/cells11162528

Ejemplares similares

The Preventive Role of the Vitamin D Endocrine System in Cervical Cancer
por: Avila, Euclides, et al.
Publicado: (2023)

Calcitriol stimulates gene expression of cathelicidin antimicrobial peptide in breast cancer cells with different phenotype
por: García-Quiroz, Janice, et al.
Publicado: (2016)

Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2021)

The Phytochemical α-Mangostin Inhibits Cervical Cancer Cell Proliferation and Tumor Growth by Downregulating E6/E7-HPV Oncogenes and KCNH1 Gene Expression
por: Díaz, Lorenza, et al.
Publicado: (2023)

Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2022)

The Inhibition of the FGFR/PI3K/Akt Axis by AZD4547 Disrupts the Proangiogenic Microenvironment and Vasculogenic Mimicry Arising from the Interplay between Endothelial and Triple-Negative Breast Cancer Cells
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2023)

Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update
por: Segovia-Mendoza, Mariana, et al.
Publicado: (2021)

Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach
por: Santos-Martínez, Nancy, et al.
Publicado: (2014)

Enhancing Tamoxifen Therapy with α-Mangostin: Synergistic Antiproliferative Effects on Breast Cancer Cells and Potential Reduced Endometrial Impact
por: Vargas-Castro, Rafael, et al.
Publicado: (2023)

Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy
por: García-Quiroz, Janice, et al.
Publicado: (2012)

Human papillomavirus genotype-specific risk in cervical carcinogenesis
por: So, Kyeong A, et al.
Publicado: (2019)

Carcinogenesis and management of human papillomavirus-associated cervical cancer
por: Kusakabe, Misako, et al.
Publicado: (2023)

Regulation of Calcitriol Biosynthesis and Activity: Focus on Gestational Vitamin D Deficiency and Adverse Pregnancy Outcomes
por: Olmos-Ortiz, Andrea, et al.
Publicado: (2015)

Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
por: García-Becerra, Rocío, et al.
Publicado: (2012)

In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors
por: García-Quiroz, Janice, et al.
Publicado: (2014)

The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis
por: Xu, Hui-Hui, et al.
Publicado: (2020)

Cord Serum Calcitriol Inversely Correlates with Maternal Blood Pressure in Urinary Tract Infection-Affected Pregnancies: Sex-Dependent Immune Implications
por: Olmos-Ortiz, Andrea, et al.
Publicado: (2021)

Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts
por: García-Quiroz, Janice, et al.
Publicado: (2019)

Development of an in vitro carcinogenesis model of human papillomavirus‐induced cervical adenocarcinoma
por: Zhang, Mengzhu, et al.
Publicado: (2021)

Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection
por: So, Kyeong A., et al.
Publicado: (2020)

Role of human papillomaviruses in carcinogenesis
por: Ghittoni, Raffaella, et al.
Publicado: (2015)

A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis
por: He, Chunbo, et al.
Publicado: (2019)

Co-carcinogenesis: Human Papillomaviruses, Coal Tar Derivatives, and Squamous Cell Cervical Cancer
por: Haverkos, Harry W., et al.
Publicado: (2017)

FNDC3B and BPGM Are Involved in Human Papillomavirus-Mediated Carcinogenesis of Cervical Cancer
por: Zhang, Luhan, et al.
Publicado: (2021)

APOBEC3A/B Polymorphism Is Not Associated with Human Papillomavirus Infection and Cervical Carcinogenesis
por: Castilha, Eliza Pizarro, et al.
Publicado: (2023)

p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
por: Busby-Earle, R. M., et al.
Publicado: (1994)

Protein Profiling in Human Papillomavirus-Associated Cervical Carcinogenesis: Cornulin as a Biomarker for Disease Progression
por: Kumarasamy, Gaayathri, et al.
Publicado: (2023)

E6-regulated overproduction of prostaglandin E2 may inhibit migration of dendritic cells in human papillomavirus 16-positive cervical lesions
por: Huang, Jie, et al.
Publicado: (2020)

Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer
por: Martínez-Reza, Isela, et al.
Publicado: (2017)

Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes
por: Pinheiro, Maisa, et al.
Publicado: (2021)

Disturbances of Vaginal Microbiome Composition in Human Papillomavirus Infection and Cervical Carcinogenesis: A Qualitative Systematic Review
por: Wu, Ming, et al.
Publicado: (2022)

Therapeutic Applications of Prostaglandins
por: Collier, Joe
Publicado: (1994)

Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: Human papillomavirus-mediated carcinogenesis
por: Feller, Liviu, et al.
Publicado: (2010)

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009)

Implications of tyrosine phosphoproteomics in cervical carcinogenesis
por: Robinson-Bennett, Bernice L, et al.
Publicado: (2008)

The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis
por: Olmedo-Nieva, Leslie, et al.
Publicado: (2018)

Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection
por: Shukla, Shirish, et al.
Publicado: (2010)

Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV‐related cervical carcinogenesis
por: Zhang, Ruiyang, et al.
Publicado: (2016)

Effects of Th17 cells and IL‐17 in the progression of cervical carcinogenesis with high‐risk human papillomavirus infection
por: Xue, JiSen, et al.
Publicado: (2017)

Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis
por: Pańczyszyn, Anna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fanov8ptplg9f0gi15ldai0g9b